Literature DB >> 25739025

Coronary endothelial dysfunction induced by nucleotide oligomerization domain-like receptor protein with pyrin domain containing 3 inflammasome activation during hypercholesterolemia: beyond inflammation.

Yang Zhang1, Xiang Li, Ashley L Pitzer, Yang Chen, Lei Wang, Pin-Lan Li.   

Abstract

AIMS: This study hypothesized that activation of endothelial nucleotide oligomerization domain-like receptor protein with pyrin domain containing 3 (Nlrp3) inflammasomes directly produces endothelial dysfunction during hypercholesterolemia, which is distinct from its canonical roles in inflammation.
RESULTS: Acute hypercholesterolemia in mice was induced by intraperitoneal administration of poloxamer 407 (0.5 g/kg) for 24 h. Endothelial dysfunction was assessed by evaluating endothelium-dependent vasodilation in isolated, perfused, and pressurized coronary arteries in response to bradykinin (10(-10)-10(-6) M) and acetylcholine (10(-9)-10(-5) M). Impaired endothelium-dependent vasodilation was observed in Nlrp3(+/+) mice with acute hypercholesterolemia, which was markedly ameliorated in Nlrp3(-/-) mice. Treatment of mice with inhibitors for caspase-1 or high mobility group box 1 (HMGB1) significantly restored endothelium-dependent vasodilation in Nlrp3(+/+) mice with acute hypercholesterolemia. Confocal microscopic analysis demonstrated that hypercholesterolemia markedly increased caspase-1 activity and HMGB1 expression in coronary arterial endothelium of Nlrp3(+/+) mice, which was absent in Nlrp3-deficient mice. Further, recombinant HMGB1 directly induced endothelial dysfunction in normal Nlrp3(+/+) coronary arteries. In vitro, Nlrp3 inflammasome formation and its activity were instigated in cultured endothelial cells by cholesterol crystal, a danger factor associated with hypercholesterolemia. Moreover, cholesterol crystals directly induced endothelial dysfunction in coronary arteries from Nlrp3(+/+) mice, which was attenuated in Nlrp3(-/-) arteries. Such cholesterol crystal-induced impairment was associated with enhanced superoxide production, downregulation of endothelial nitric oxide synthase activity, and pyroptosis. INNOVATION AND
CONCLUSION: Our data provide the first evidence that activation of endothelial Nlrp3 inflammasome directly impairs endothelial function beyond its canonical inflammatory actions. This novel non-canonical action of Nlrp3 inflammasomes may initiate or exacerbate vascular injury during hypercholesterolemia.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25739025      PMCID: PMC4403230          DOI: 10.1089/ars.2014.5978

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  57 in total

1.  Protection of podocytes from hyperhomocysteinemia-induced injury by deletion of the gp91phox gene.

Authors:  Chun Zhang; Jun-Jun Hu; Min Xia; Krishna M Boini; Christopher A Brimson; Laura A Laperle; Pin-Lan Li
Journal:  Free Radic Biol Med       Date:  2010-01-29       Impact factor: 7.376

2.  Thioredoxin-interacting protein is required for endothelial NLRP3 inflammasome activation and cell death in a rat model of high-fat diet.

Authors:  Islam N Mohamed; Sherif S Hafez; Arwa Fairaq; Adviye Ergul; John D Imig; Azza B El-Remessy
Journal:  Diabetologia       Date:  2013-11-08       Impact factor: 10.122

3.  Inhibition of ceramide-redox signaling pathway blocks glomerular injury in hyperhomocysteinemic rats.

Authors:  F Yi; A Y Zhang; N Li; R W Muh; M Fillet; A-F Renert; P-L Li
Journal:  Kidney Int       Date:  2006-05-10       Impact factor: 10.612

4.  NLRP1 inflammasome, and not NLRP3, is the key in the shift to proinflammatory state on endothelial cells in peripheral arterial disease.

Authors:  Silvia Bleda; Joaquin de Haro; Cesar Varela; Leticia Esparza; Antonio Ferruelo; Francisco Acin
Journal:  Int J Cardiol       Date:  2014-01-09       Impact factor: 4.164

Review 5.  A role for the NLRP3 inflammasome in metabolic diseases--did Warburg miss inflammation?

Authors:  Haitao Wen; Jenny P-Y Ting; Luke A J O'Neill
Journal:  Nat Immunol       Date:  2012-03-19       Impact factor: 25.606

Review 6.  Sterile inflammation: sensing and reacting to damage.

Authors:  Grace Y Chen; Gabriel Nuñez
Journal:  Nat Rev Immunol       Date:  2010-11-19       Impact factor: 53.106

Review 7.  Dangers within: DAMP responses to damage and cell death in kidney disease.

Authors:  Diane L Rosin; Mark D Okusa
Journal:  J Am Soc Nephrol       Date:  2011-02-18       Impact factor: 10.121

8.  Homocysteine activates NADH/NADPH oxidase through ceramide-stimulated Rac GTPase activity in rat mesangial cells.

Authors:  Fan Yi; Andrew Y Zhang; Jennifer L Janscha; Pin-Lan Li; Ai-Ping Zou
Journal:  Kidney Int       Date:  2004-11       Impact factor: 10.612

Review 9.  Cell death, damage-associated molecular patterns, and sterile inflammation in cardiovascular disease.

Authors:  Yue Zheng; Sarah E Gardner; Murray C H Clarke
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-12       Impact factor: 8.311

10.  TRAIL death receptor 4 signaling via lysosome fusion and membrane raft clustering in coronary arterial endothelial cells: evidence from ASM knockout mice.

Authors:  Xiang Li; Wei-Qing Han; Krishna M Boini; Min Xia; Yang Zhang; Pin-Lan Li
Journal:  J Mol Med (Berl)       Date:  2012-10-24       Impact factor: 4.599

View more
  34 in total

1.  Cardiovascular pathobiology of inflammasomes: inflammatory machinery and beyond.

Authors:  Pin-Lan Li
Journal:  Antioxid Redox Signal       Date:  2015-04-01       Impact factor: 8.401

Review 2.  Cell death in chronic inflammation: breaking the cycle to treat rheumatic disease.

Authors:  Holly Anderton; Ian P Wicks; John Silke
Journal:  Nat Rev Rheumatol       Date:  2020-07-08       Impact factor: 20.543

3.  Research progress of the relationship between pyroptosis and disease.

Authors:  Yuze Ma; Jiaxuan Jiang; Yuan Gao; Tianshu Shi; Xiaobo Zhu; Kaijia Zhang; Ke Lu; Bin Xue
Journal:  Am J Transl Res       Date:  2018-07-15       Impact factor: 4.060

Review 4.  Inflammasomes link vascular disease with neuroinflammation and brain disorders.

Authors:  Nikolett Lénárt; David Brough; Ádám Dénes
Journal:  J Cereb Blood Flow Metab       Date:  2016-08-02       Impact factor: 6.200

Review 5.  Redox regulation of NLRP3 inflammasomes: ROS as trigger or effector?

Authors:  Justine M Abais; Min Xia; Yang Zhang; Krishna M Boini; Pin-Lan Li
Journal:  Antioxid Redox Signal       Date:  2015-01-19       Impact factor: 8.401

6.  Contribution of redox-dependent activation of endothelial Nlrp3 inflammasomes to hyperglycemia-induced endothelial dysfunction.

Authors:  Yang Chen; Lei Wang; Ashley L Pitzer; Xiang Li; Pin-Lan Li; Yang Zhang
Journal:  J Mol Med (Berl)       Date:  2016-10-25       Impact factor: 4.599

Review 7.  Emerging Roles of Inflammasomes in Cardiovascular Diseases.

Authors:  Yingnan Liao; Kui Liu; Liyuan Zhu
Journal:  Front Immunol       Date:  2022-04-07       Impact factor: 8.786

8.  Attenuating Effects of Dieckol on High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease by Decreasing the NLRP3 Inflammasome and Pyroptosis.

Authors:  Seyeon Oh; Myeongjoo Son; Kyung-A Byun; Ji Tae Jang; Chang Hu Choi; Kuk Hui Son; Kyunghee Byun
Journal:  Mar Drugs       Date:  2021-05-30       Impact factor: 5.118

9.  Induction of NLRP3 Inflammasome Activation by Heme in Human Endothelial Cells.

Authors:  Judit Erdei; Andrea Tóth; Enikő Balogh; Benard Bogonko Nyakundi; Emese Bányai; Bernhard Ryffel; György Paragh; Mario D Cordero; Viktória Jeney
Journal:  Oxid Med Cell Longev       Date:  2018-03-20       Impact factor: 6.543

10.  Differential effects of short chain fatty acids on endothelial Nlrp3 inflammasome activation and neointima formation: Antioxidant action of butyrate.

Authors:  Xinxu Yuan; Lei Wang; Owais M Bhat; Hannah Lohner; Pin-Lan Li
Journal:  Redox Biol       Date:  2018-02-13       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.